TARDBP and neuroblastoma: To assess whether GSK3 inhibition influences TDP-43 fragmentation, SH-SY5Y neuroblastoma cells expressing TDP-43N-Del, TDP-43WT, or TDP-43Q331K were treated with CHIR99021 (Fig. 4a).